Pleural Diseases Market Owing To Rising Prevalence Of Lung Cancer

Pleural Diseases Market


 Market Overview:

Pleural diseases market involves products that are used to treat pleural diseases conditions such as pleurisy, pneumothorax, pleural effusion, and mesothelioma. The key products in this market include pleural catheters, thoracentesis devices, biopsy devices, and others. Pleural effusion is one of the most common conditions indicating excess fluid build up between the chest wall and lungs which requires drainage using pleural catheters or thoracentesis devices.

Market Dynamics:
The rising prevalence of lung cancer is one of the major drivers of the pleural diseases market. For instance, according to the American Cancer Society, lung cancer accounts for about 25% of all cancer deaths and is the second most common cancer. Around 235,760 new cases of lung cancer were diagnosed and over 131,880 deaths from lung cancer occurred in 2018 in the United States. Furthermore, increasing adoption of minimally invasive procedures for drainage and biopsy of pleural effusion is also fueling the market growth. For instance, video-assisted thoracoscopic surgery allows drainage of pleural effusions and biopsy of pleural tissues using small incisions instead of large incisions. However, high cost of pleural biopsy and drainage procedures may hamper market growth over the forecast period.

SWOT Analysis

Strength: Pleural Diseases market has strong growth potential owing to rising cases of respiratory diseases across the globe. Well-established healthcare infrastructure and increasing awareness about pleural diseases are positively impacting the market growth. Various treatment options available for pleural diseases provides advantage to market players.

Weakness: High cost associated with pleural disease treatment limits penetration in low and middle income countries. Lack of diagnostic infrastructure and skilled professionals in underdeveloped regions poses challenges to market.

Opportunity: Growing geriatric population prone to pleural diseases acts as high impact rendering opportunity. Advancements in drug delivery systems and minimally invasive procedures can boost market opportunities.

Threats: Compliance challenges associated with lengthy treatment protocols reduce treatment adherence. Adverse effects of some existing drugs limit product penetration.

Key Takeaways:

The Global Pleural Diseases Market Demand is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing prevalence of respiratory diseases as a result of surge in pollution levels and changing lifestyle. According to Market Size for 2023 is US$ 3.84 Bn.

Regional analysis North America dominates the global Pleural Diseases market owing to rising healthcare spending and affordability of advanced treatment options in countries like United States and Canada. Europe accounts for significant market share due to presence of major market players and supportive government initiatives to strengthen healthcare system in the region. However, Asia Pacific represents fastest growing region on back of growing medical tourism, improving healthcare infrastructure and expanding target patient base in countries like India and China.

Key players operating in the Pleural Diseases market are Johnson & Johnson, AstraZeneca, Novartis International AG, Roche Holding AG, Bristol Myers Squibb, Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Bayer AG, Celgene Corporation. Companies adopt competitive strategies such as mergers, acquisitions and collaborations to strengthen product portfolio and sustain market position.

Read More:

https://www.marketwebjournal.com/pleural-diseases-market-share-growth-and-overview/

Comments

Post a Comment

Popular posts from this blog

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million adul
Read more

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the majo
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more